Evidence map›Paper›PMID 29633922›Full record

ReviewVascular medicine (London, England)2018

Recent advances in magnetic resonance imaging for peripheral artery disease.

Roshin C Mathew, Christopher M Kramer

Abstract readReview
In one paragraph

Review in Vascular medicine (London, England), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Observational
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Roshin C MathewDepartments of Medicine (Cardiology) and Radiology, University of Virginia Health System, Charlottesville, VA, USA.ORCID 0000-0002-7927-4607
Christopher M KramerDepartments of Medicine (Cardiology) and Radiology, University of Virginia Health System, Charlottesville, VA, USA.

Funding

Comprehensive Magnetic Resonance in PADR01HL075792 · NHLBI · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI KRAMER, CHRISTOPHER M. · 2003 to 2021
$10.5M
Training in Cardiovascular Imaging ResearchT32EB003841 · NIBIB · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI Jonathan R Lindner · 2004 to 2026
$4.4M
NHLBI NIH HHS R01 HL075792NIBIB NIH HHS T32 EB003841
6 · The paper itself

Abstract

The global burden of peripheral artery disease (PAD) is significant. This has led to numerous recent advances in magnetic resonance imaging (MRI) techniques in PAD. Older techniques such as time of flight MRI or phase contrast MRI are burdened by long acquisition times and significant issues with artifacts. In addition, the most used MRI modality, contrast-enhanced MR angiography (CE-MRA) is limited by the use of gadolinium contrast and its potential toxicity. Novel MRI techniques such as arterial spin labeling (ASL), blood-oxygen-level dependent imaging (BOLD), and first-pass perfusion gadolinium enhancement are advancing the field by providing skeletal muscle perfusion/oxygenation data while maintaining excellent spatial and temporal resolution. Perfusion data can be critical to providing objective clinical data of a visualized stenosis. In addition, there are a number of new MRI sequences assessing plaque composition and lesion severity in the absence of contrast. These approaches used in combination can provide useful clinical and prognostic data and provide critical endpoints in PAD research.

Indexed as

Magnetic Resonance AngiographyMagnetic Resonance ImagingArteriesContrast MediaHumansMuscle, SkeletalPeripheral Arterial DiseaseContrast Mediaarterial spin labelingblood-oxygen-level dependent imagingfirst-pass gadolinium enhanced imagingmagnetic resonance angiography (MRA)magnetic resonance imaging (MRI)magnetic resonance spectroscopyperipheral artery disease (PAD)peripheral artery plaquephosphocreatine

Identifiers

PMID29633922
PMCPMC5909975

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.